| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Addressing logistical barriers to childhood vaccination using an automated reminder system and online resource intervention: A randomized controlled trial
|
Wagner, Nicole M.
|
|
|
39 |
29 |
p. 3983-3990
|
article
|
| 2 |
Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents
|
Bardenheier, Barbara H.
|
|
|
39 |
29 |
p. 3844-3851
|
article
|
| 3 |
Antigenic evolution of contemporary clade 2.3.4.4 HPAI H5 influenza A viruses and impact on vaccine use for mitigation and control
|
Lewis, Nicola S
|
|
|
39 |
29 |
p. 3794-3798
|
article
|
| 4 |
A protein A based Staphylococcus aureus vaccine with improved safety
|
Shi, Miaomiao
|
|
|
39 |
29 |
p. 3907-3915
|
article
|
| 5 |
Assessment of immunogenicity and safety across two manufacturing lots of a 3-antigen hepatitis B vaccine, Sci-B-Vac®, compared with Engerix-B® in healthy Asian adults: A phase 3 randomized clinical trial
|
Diaz-Mitoma, Francisco
|
|
|
39 |
29 |
p. 3892-3899
|
article
|
| 6 |
Association of vaccine hesitancy and immunization coverage rates in the European Union
|
Stoeckel, Florian
|
|
|
39 |
29 |
p. 3935-3939
|
article
|
| 7 |
Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe – Results from the DRIVE EU study platform
|
Stuurman, Anke L.
|
|
|
39 |
29 |
p. 3964-3973
|
article
|
| 8 |
Changes in childhood vaccination during the coronavirus disease 2019 pandemic in Japan
|
Aizawa, Yuta
|
|
|
39 |
29 |
p. 4006-4012
|
article
|
| 9 |
COVID-19 vaccine hesitancy: Lessons from Israel
|
Gurwitz, David
|
|
|
39 |
29 |
p. 3785-3786
|
article
|
| 10 |
Development of a platform-based approach for the clinical production of HIV gp120 envelope glycoprotein vaccine candidates
|
Wolfe, Leslie S.
|
|
|
39 |
29 |
p. 3852-3861
|
article
|
| 11 |
Don’t forget about the future: The impact of including future costs on the cost-effectiveness of adult pneumococcal conjugate vaccination with PCV13 in the Netherlands
|
de Vries, L.M.
|
|
|
39 |
29 |
p. 3834-3843
|
article
|
| 12 |
Editorial Board/Aims and Scope
|
|
|
|
39 |
29 |
p. IFC
|
article
|
| 13 |
Effectiveness of the recombinant zoster vaccine among Kaiser Permanente Hawaii enrollees aged 50 and older: A retrospective cohort study
|
Sun, Yuwei
|
|
|
39 |
29 |
p. 3974-3982
|
article
|
| 14 |
Effects of three commercial vaccines against porcine parvovirus 1 in pregnant gilts
|
Noguera, Marta
|
|
|
39 |
29 |
p. 3997-4005
|
article
|
| 15 |
Factors influencing acceptance of vaccination during pregnancy in The Gambia and Senegal
|
Johm, Penda
|
|
|
39 |
29 |
p. 3926-3934
|
article
|
| 16 |
Health inequities related to vaccination: An evidence map of potentially influential factors and systematic review of interventions
|
Gates, Allison
|
|
|
39 |
29 |
p. 3825-3833
|
article
|
| 17 |
HPV vaccine: Expanding indications and global disparity
|
Uwins, Christina
|
|
|
39 |
29 |
p. 3787-3789
|
article
|
| 18 |
Knowledge and attitude of Kenyan healthcare workers towards pandemic influenza disease and vaccination: 9 years after the last influenza pandemic
|
Andayi, Fred
|
|
|
39 |
29 |
p. 3991-3996
|
article
|
| 19 |
Methodologic approaches in studies using real-world data (RWD) to measure pediatric safety and effectiveness of vaccines administered to pregnant women: A scoping review
|
Lasky, Tamar
|
|
|
39 |
29 |
p. 3814-3824
|
article
|
| 20 |
Myocarditis following COVID-19 mRNA vaccination
|
Abu Mouch, Saif
|
|
|
39 |
29 |
p. 3790-3793
|
article
|
| 21 |
Optimising HPV vaccination communication to adolescents: A discrete choice experiment
|
Chyderiotis, Sandra
|
|
|
39 |
29 |
p. 3916-3925
|
article
|
| 22 |
Physician attitudes regarding the Advisory Committee on Immunization Practices Adult Immunization Schedule
|
Crawford, Jordan A.
|
|
|
39 |
29 |
p. 3799-3802
|
article
|
| 23 |
Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells
|
Shingai, Masashi
|
|
|
39 |
29 |
p. 3940-3951
|
article
|
| 24 |
Preclinical safety assessment of a combined vaccine against Hepatitis a virus and enterovirus 71
|
Yang, Ting
|
|
|
39 |
29 |
p. 3952-3963
|
article
|
| 25 |
Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial
|
Chua, Joel V.
|
|
|
39 |
29 |
p. 3879-3891
|
article
|
| 26 |
Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine: A randomized, double-blind, active-controlled phase 1 clinical trial
|
Wang, Yanxia
|
|
|
39 |
29 |
p. 3871-3878
|
article
|
| 27 |
Serum antibody levels to pneumococcal polysaccharides 22F, 33F, 19A and 6A that correlate with protection from colonization and acute otitis media in children
|
Kaur, Ravinder
|
|
|
39 |
29 |
p. 3900-3906
|
article
|
| 28 |
Single-dose combination nanovaccine induces both rapid and durable humoral immunity and toxin neutralizing antibody responses against Bacillus anthracis
|
Kelly, Sean M.
|
|
|
39 |
29 |
p. 3862-3870
|
article
|
| 29 |
The burden of Respiratory Syncytial Virus (RSV) infection in the Middle East and North Africa (MENA) region across age groups: A systematic review
|
Youssef, Yolla
|
|
|
39 |
29 |
p. 3803-3813
|
article
|
Journal description